Skip to main content

Advertisement

SpringerLink
Log in

Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The Hector Battifora mesothelial epitope-1 (HBME-1) monoclonal antibody has been generated against human mesothelioma cells and recognizes a biochemically unknown membrane epitope. We have accidentally found that the HBME-1 reacts with scattered lymphocytes showing villous surface in hyperplastic lymphoid tissue. To evaluate its reactivity pattern, we have performed a consecutive immunohistochemical study in nonneoplastic bone marrow and lymphoid samples (n = 40), as well as in malignant lymphoproliferations (n = 427), including hairy cell leukemia (HCL) (n = 72), HCL variant (HCL-v) (n = 13), splenic diffuse red pulp small B cell lymphoma (SDRPL) (n = 8), splenic B cell marginal zone lymphoma (SMZL) (n = 59), and splenic B cell lymphoma/leukemia, not further classifiable on bone marrow morphology (SBCL) (n = 37) cases. The staining pattern of HBME-1 was compared to DBA.44. HBME-1+ villous lymphocytes were constantly detected in low number in nonneoplastic lymphoid tissues. With multicolor immunofluorescence staining, HBME-1+ lymphocytes showed a CD20+/CD79a+/IgM+ B cell phenotype. In B cell lymphoproliferations of villous lymphocytes, HBME-1 reactivity was demonstrated in 96 % of HCL, 39 % of HCL-v, 50 % of SDRPL, 12 % of SMZL, and 19 % of SBCL cases. Nodal and extranodal marginal zone lymphoma cases were positive in 12 % of the cases. A small minority (4 %) of the other B cell lymphomas and no T cell lymphoma revealed tumor cell reactivity with HBME-1. In conclusion, our study has established that HBME-1 reacts with a minor subset of B lymphocytes and a small proportion of B cell lymphomas, which has not been described previously. We suggest that HBME-1 can be a useful marker in the diagnosis of HCL and other indolent lymphoproliferations of villous B lymphocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Andrulis M, Penzel R, Weichert W, von Deimling A, Capper D (2012) Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia. Am J Surg Pathol 36:1796–1800. doi:10.1097/PAS.0b013e3182549b50

    Article  PubMed  Google Scholar 

  2. Ascoli V, Carnovale-Scalzo C, Taccogna S, Nardi F (1997) Utility of HBME-1 immunostaining in serous effusions. Cytopathology 8:328–335

    Article  PubMed  CAS  Google Scholar 

  3. Chen YH, Tallman MS, Goolsby C, Peterson L (2006) Immunophenotypic variations in hairy cell leukemia. Am J Clin Pathol 125:251–259. doi:10.1309/PMQXVY619Q8Y43AR

    PubMed  Google Scholar 

  4. Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F, A’Hern R, Delgado J, Bazerbashi MB, Catovsky D (2004) The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica 89:303–308

    PubMed  Google Scholar 

  5. de Matos LL, Del Giglio AB, Matsubayashi CO, de Lima FM, Del Giglio A, da Silva Pinhal MA (2012) Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. Diagn Pathol 7:97. doi:10.1186/1746-1596-7-97

    Article  PubMed  Google Scholar 

  6. Dische FE, Darby AJ, Howard ER (1978) Malignant synovioma: electron microscopical findings in three patients and review of the literature. J Pathol 124:149–155

    Article  PubMed  CAS  Google Scholar 

  7. Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R, Foa R, Pulsoni A, Dalla Favera R, Pileri S (2004) Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 363:1869–1870

    Article  PubMed  CAS  Google Scholar 

  8. Foucar K, Falini B, Catovsky D, Stein H (2008) Hairy cell leukaemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, vol 2, 4th edn, WHO classification of tumours. IARC, Lyon, pp 188–190

    Google Scholar 

  9. Frisch B, Bartl R (eds) (1999) Biopsy interpretation of bone and bone marrow, 2nd edn. Arnold, London–Sidney–Auckland, p 350

    Google Scholar 

  10. Heimburg-Molinaro J, Rittenhouse-Olson K (2009) Development and characterization of antibodies to carbohydrate antigens. Methods Mol Biol 534:341–357. doi:10.1007/978-1-59745-022-5_24

    PubMed  CAS  Google Scholar 

  11. Hounieu H, Chittal SM, al Saati T, de Mascarel A, Sabattini E, Pileri S, Falini B, Ralfkiaer E, Le Tourneau A, Selves J et al (1992) Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44. Am J Clin Pathol 98:26–33

    PubMed  CAS  Google Scholar 

  12. Hoyer JD, Li CY, Yam LT, Hanson CA, Kurtin PJ (1997) Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders. Am J Clin Pathol 108:308–315

    PubMed  CAS  Google Scholar 

  13. Isaacson PG, Piris MA, Berger F, Swerdlow SH, Thieblemont C, Pittaluga S, Harris NL (2008) Splenic B-cell marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, vol 2, WHO classification of tumours. IARC, Lyon, pp 185–187

    Google Scholar 

  14. Janckila AJ, Cardwell EM, Yam LT, Li CY (1995) Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase. Blood 85:2839–2844

    PubMed  CAS  Google Scholar 

  15. Kanellis G, Mollejo M, Montes-Moreno S, Rodriguez-Pinilla SM, Cigudosa JC, Algara P, Montalban C, Matutes E, Wotherspoon A, Piris MA (2009) Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica 95:1122–1129. doi:10.3324/haematol.2009.013714

    Article  Google Scholar 

  16. Marafioti T, Jones M, Facchetti F, Diss TC, Du MQ, Isaacson PG, Pozzobon M, Pileri SA, Strickson AJ, Tan SY, Watkins F, Mason DY (2003) Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 102:2868–2876

    Article  PubMed  CAS  Google Scholar 

  17. Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D (1994) The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorder with hairy or villous lymphocytes. Leuk Lymphoma 14:57–61

    PubMed  Google Scholar 

  18. Matutes E, Wotherspoon A, Brito-Babapulle V, Catovsky D (2001) The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia 15:184–186

    Article  PubMed  CAS  Google Scholar 

  19. Miettinen M, Kovatich AJ (1995) HMBE-1 a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft-tissue and bone tumors. Appl Immunohistochem 3:115–322

    Google Scholar 

  20. Miettinen M, Karkkainen P (1996) Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours: preferential reactivity with malignant tumours. Virchows Arch 429:213–219

    PubMed  CAS  Google Scholar 

  21. Miettinen M, Limon J, Niezabitowski A, Lasota J (2001) Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol 25:610–617

    Article  PubMed  CAS  Google Scholar 

  22. Miranda RN, Briggs RC, Kinney MC, Veno PA, Hammer RD, Cousar JB (2000) Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol 13:1308–1314

    Article  PubMed  CAS  Google Scholar 

  23. Morgan EA, Yu H, Pinkus JL, Pinkus GS (2013) Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody. Am J Clin Pathol 139:220–230. doi:10.1309/AJCPHW7RULIZT2GB

    Article  PubMed  Google Scholar 

  24. Nesland JM, Sobrinho-Simoes M, Johannessen JV (1987) Scanning electron microscopy of the human thyroid gland and its disorders. Scanning Microsc 1:1797–1810

    PubMed  CAS  Google Scholar 

  25. O’Hara BJ, Paetau A, Miettinen M (1998) Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol 29:119–126

    Article  PubMed  Google Scholar 

  26. Ordóñez NG (1998) Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 22:1203–1214

    Article  PubMed  Google Scholar 

  27. Pardo-Mindan FJ, Guillen FJ, Villas C, Vazquez JJ (1981) A comparative ultrastructural study of chondrosarcoma, chordoid sarcoma, and chordoma. Cancer 47:2611–2619

    Article  PubMed  CAS  Google Scholar 

  28. Piris M, Foucar K, Mollejo M, Campo E, Falini B (2008) Splenic B-cell lymphoma/leukaemia, unclassifiable. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, vol 2, 4th edn, WHO classification of tumours. IARC, Lyon, pp 191–193

    Google Scholar 

  29. Ponzoni M, Kanellis G, Pouliou E, Baliakas P, Scarfò L, Ferreri AJ, Doglioni C, Bikos V, Dagklis A, Anagnostopoulos A, Ghia P, Stamatopoulos K, Papadaki T (2012) Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology? Am J Surg Pathol 36:1609–1618. doi:10.1097/PAS.0b013e318271243d

    Article  PubMed  Google Scholar 

  30. Raju U, Fine G, Greenawald KA, Ohorodnik JM (1989) Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases. Hum Pathol 20:426–436

    Article  PubMed  CAS  Google Scholar 

  31. Robbins BA, Ellison DJ, Spinosa JC, Carey CA, Lukes RJ, Poppema S, Saven A, Piro LD (1993) Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 82:1277–1287

    PubMed  CAS  Google Scholar 

  32. Sadik W, Coupland S, Thachil J (2010) Hairy cell leukaemia, negative for conventional cell markers, diagnosed using antibodies to annexin A1 and T-bet. Br J Haematol 151:207. doi:10.1111/j.1365-2141.2010.08359.x

    Article  PubMed  Google Scholar 

  33. Sainati L, Matutes E, Mulligan S, de Oliveira MP, Rani S, Lampert IA, Catovsky D (1990) A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. Blood 76:157–162

    PubMed  CAS  Google Scholar 

  34. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM (1992) Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 23:107–116

    Article  PubMed  CAS  Google Scholar 

  35. Sherman MJ, Hanson CA, Hoyer JD (2011) An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia. Am J Clin Pathol 136:390–399. doi:10.1309/AJCP5GE1PSBMBZTW

    Article  PubMed  Google Scholar 

  36. Tiacci E, Schiavoni G, Martelli MP, Boveri E, Pacini R, Tabarrini A, Zibellini S, Santi A, Pettirossi V, Fortini E, Ascani S, Arcaini L, Inghirami G, Paulli M, Falini B (2013) Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. Haematologica 98:635–639. doi:10.3324/haematol.2012.078071

    Article  PubMed  CAS  Google Scholar 

  37. Venkatraman L, McDonald KA, Bagdi E, Krenacs L, Piggott N, McIntosh G, Dogan A (2005) Characterisation of a new monoclonal antibody recognising CD11c in paraffin-embedded tissue. Mod Pathol 18:255A–256A, 1183 Suppl.1

    Google Scholar 

  38. Went PT, Zimpfer A, Pehrs AC, Sabattini E, Pileri SA, Maurer R, Terracciano L, Tzankov A, Sauter G, Dirnhofer S (2005) High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia. Am J Surg Pathol 29:474–478

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ágnes Dudás, Anita Jancsó, and Hedvig Dósa for their excellent technical contribution.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Laboratory of Tumor Pathology and Molecular Diagnostics, Derkovits fasor 7-11, 6726, Szeged, Hungary

    László Krenács, Judit Tóth-Lipták & Enikő Bagdi

  2. 1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary

    Judit Demeter & Eszter Sári

  3. 2nd Department of Internal Medicine, Faculty of General Medicine, University of Szeged, Szeged, Hungary

    Klára Piukovics & Zita Borbényi

  4. Department of Immunology, Faculty of Medicine, Medical & Health Science Centre, University of Debrecen, Debrecen, Hungary

    Péter Gogolák

Authors
  1. László Krenács
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judit Tóth-Lipták
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Judit Demeter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Klára Piukovics
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zita Borbényi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Péter Gogolák
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eszter Sári
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Enikő Bagdi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to László Krenács.

Additional information

L. Krenács and J. Tóth-Lipták contributed equally to this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 247 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krenács, L., Tóth-Lipták, J., Demeter, J. et al. Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes. Virchows Arch 463, 787–794 (2013). https://doi.org/10.1007/s00428-013-1490-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-013-1490-5

Keywords

Search

Navigation